molecular function |
| GO:0000340 | | RNA 7-methylguanosine cap binding | | Interacting selectively and non-covalently with the 7-methylguanosine group added cotranscriptionally to the 5' end of RNA molecules transcribed by polymerase II. |
| GO:0003723 | | RNA binding | | Interacting selectively and non-covalently with an RNA molecule or a portion thereof. |
| GO:0000339 | | RNA cap binding | | Interacting selectively and non-covalently with a 7-methylguanosine (m7G) group or derivative located at the 5' end of an RNA molecule. |
| GO:0031370 | | eukaryotic initiation factor 4G binding | | Interacting selectively and non-covalently with eukaryotic initiation factor 4G, a polypeptide factor involved in the initiation of ribosome-mediated translation. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0003743 | | translation initiation factor activity | | Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide. |
biological process |
| GO:0016070 | | RNA metabolic process | | The cellular chemical reactions and pathways involving RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage. |
| GO:0048102 | | autophagic cell death | | A form of programmed cell death that is accompanied by the formation of autophagosomes. Autophagic cell death is characterized by lack of chromatin condensation and massive vacuolization of the cytoplasm, with little or no uptake by phagocytic cells. |
| GO:0002191 | | cap-dependent translational initiation | | The process where the "Cap structure" (composed of a 7- methylguanosine (m7G) group and associated cap-binding proteins) located at the 5' end of an mRNA molecule, which serves as a "molecular tag" that marks the spot where the 40S ribosomal subunit is recruited and will then scan in a 5' to 3' direction until an AUG codon is encountered in an appropriate sequence context to initiate mRNA translation. |
| GO:0006325 | | chromatin organization | | Any process that results in the specification, formation or maintenance of the physical structure of eukaryotic chromatin. |
| GO:0016321 | | female meiosis chromosome segregation | | The cell cycle process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets during the meiotic cell cycle in a female. |
| GO:0048136 | | male germ-line cyst formation | | Formation of a group of interconnected cells derived from a single male gonial founder cell. |
| GO:0007060 | | male meiosis chromosome segregation | | The cell cycle process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets during the meiotic cell cycle in a male. |
| GO:0007112 | | male meiosis cytokinesis | | A cell cycle process that occurs as part of the male meiotic cell cycle and results in the division of the cytoplasm of a cell to produce two daughter cells. |
| GO:0010032 | | meiotic chromosome condensation | | Compaction of chromatin structure prior to meiosis in eukaryotic cells. |
| GO:0007076 | | mitotic chromosome condensation | | The cell cycle process in which chromatin structure is compacted prior to and during mitosis in eukaryotic cells. |
| GO:0000022 | | mitotic spindle elongation | | The cell cycle process in which the distance is lengthened between poles of the mitotic spindle. Mitotic spindle elongation begins during mitotic prophase and ends during mitotic anaphase B. |
| GO:0007052 | | mitotic spindle organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a mitotic cell cycle. |
| GO:0022008 | | neurogenesis | | Generation of cells within the nervous system. |
| GO:0030307 | | positive regulation of cell growth | | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
| GO:0001558 | | regulation of cell growth | | Any process that modulates the frequency, rate, extent or direction of cell growth. |
| GO:0045995 | | regulation of embryonic development | | Any process that modulates the frequency, rate or extent of embryonic development. |
| GO:0006417 | | regulation of translation | | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| GO:0035071 | | salivary gland cell autophagic cell death | | The stage-specific programmed cell death of salivary gland cells during salivary gland histolysis. |
| GO:0048515 | | spermatid differentiation | | The process whose specific outcome is the progression of a spermatid over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. |
| GO:0048137 | | spermatocyte division | | The meiotic divisions undergone by the primary and secondary spermatocytes to produce haploid spermatids. |
| GO:0006412 | | translation | | The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome. |
| GO:0006413 | | translational initiation | | The process preceding formation of the peptide bond between the first two amino acids of a protein. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA. |
cellular component |
| GO:0000932 | | P-body | | A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0016281 | | eukaryotic translation initiation factor 4F complex | | The eukaryotic translation initiation factor 4F complex is composed of eIF4E, eIF4A and eIF4G; it is involved in the recognition of the mRNA cap, ATP-dependent unwinding of the 5'-terminal secondary structure and recruitment of the mRNA to the ribosome. |
| GO:0005845 | | mRNA cap binding complex | | Any protein complex that binds to an mRNA cap at any time in the lifetime of the mRNA. |
| GO:0005875 | | microtubule associated complex | | Any multimeric complex connected to a microtubule. |
| GO:0097482 | | muscle cell postsynaptic density | | A postsynaptic specialization that is part of a neuromuscular junction. |
| GO:0031594 | | neuromuscular junction | | The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential. |